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ABSTRACT
Background Multiple sclerosis (MS) is a chronic,
inﬂammatory demyelinating disease of the central
nervous system, believed to be triggered by an
autoimmune reaction to myelin. Recently,
a fundamentally different pathomechanism termed
‘chronic cerebrospinal venous insufﬁciency’ (CCSVI) was
proposed, provoking signiﬁcant attention in the media
and scientiﬁc community.
Methods Twenty MS patients (mean age
42.2613.3 years; median Extended Disability Status
Scale 3.0, range 0e6.5) were compared with 20 healthy
controls. Extra- and intracranial venous ﬂow direction
was assessed by colour-coded duplex sonography, and
extracranial venous cross-sectional area (VCSA) of the
internal jugular and vertebral veins (IJV/VV) was
measured in B-mode to assess the ﬁve previously
proposed CCSVI criteria. IJV-VCSA#0.3 cm
2 indicated
‘stenosis,’ and IJV-VCSA decrease from supine to upright
position ‘reverted postural control.’ The sonographer,
data analyser and statistician were blinded to the
patient/control status of the participants.
Results No participant showed retrograde ﬂow of
cervical or intracranial veins. IJV-VCSA#0.3 cm
2 was
found in 13 MS patients versus 16 controls (p¼0.48).
A decrease in IJV-VCSA from supine to upright position
was observed in all participants, but this denotes
a physiological ﬁnding. No MS patient and one control
had undetectable IJV ﬂow despite deep inspiration
(p¼0.49). Only one healthy control and no MS patients
fulﬁlled at least two criteria for CCSVI.
Conclusions This triple-blinded extra- and transcranial
duplex sonographic assessment of cervical and cerebral
veins does not provide supportive evidence for the
presence of CCSVI in MS patients. The ﬁndings cast
serious doubt on the concept of CCSVI in MS.
INTRODUCTION
Multiple sclerosis (MS) is a chronic, inﬂammatory
disease of the central nervous system, with
substantially heterogeneous clinical features due to
variable extents of degeneration and inﬂammation.
The prevalence is estimated at 30/100000, trans-
lating to more than two million MS-patients
worldwide. The hallmark of MS is the perivenous
white-matter lesion,
1 characterised by local
inﬂammation, de- and remyelination, and local
astrogliosis.
2 The most widely accepted hypothesis
on the origin of MS is a primary autoimmune
disease, mediated by auto-reactive, oligodendro-
cyte-speciﬁc Tcells.
34
Recently a new hypothesis on the genesis of
MS was raised, fundamentally divergent from
established autoimmunological theories.
5e7 In
a recent study
5 based on duplex sonographic and
venographic assessment of extracranial and intra-
cranial veins of 65 MS patients and 235 controls,
Zamboni et al claimed a perfect coincidence of MS
andvenousstenosesinvariouslocations.Proposinga
pathophysiological mechanism of ‘venous conges-
tion,’ analogous to lower-limb chronic venous
insufﬁciency (CVI),
8 they interpreted the predomi-
nantly venotopic location of MS lesions as a conse-
quence of local erythrocyte extravasation owing to
elevated transmural venous pressure, followed by
erythrocyte degradation and iron-driven phagocy-
tosis.
6 This concept was named ‘chronic cerebro-
spinal venous insufﬁciency’ (CCSVI).
56
The idea of venous congestion as a possible
contributor to the pathogenesis of MS has been
discussed for the past 40 years,
9e12 but remained
widely unappreciated by the scientiﬁc community.
Until recently, no scientiﬁc attempt was under-
taken to prove or disprove the hypothesis despite
its potential therapeutic implications. Therefore,
the exceptionally signiﬁcant results presented by
Zamboni et al
56generated extraordinary interest. Is
it possible that we have overlooked something so
obvious for so long?
The aim of this study was to conﬁrm the data
presented by Zamboni et al.
5 A critical and inde-
pendent re-evaluation of the CCSVI hypothesis is
of particular importance, given that attempts of
endovascular treatment by percutaneous trans-
luminal angioplasty, as suggested by Zamboni and
coworkers,
7 were already complicated by serious
adverse events in two cases.
13
METHODS
Subjects
Twenty MS patients and 20 healthy controls
participated (table 1). Exclusion criteria for patients
and controls were: previous history of thrombo-
philia or cerebrovascular diseases including
migraine, idiopathic intracranial hypertension,
intracranial sinus thrombosis, thrombosis of
jugular veins and neck dissection. Patients with a
relapse within 30 days before investigation were
excluded. All participants gave their written
informed consent. We included 17 relapsing-remit-
ting and three secondary-progressive patients from
our MS outpatient clinic. All patients fulﬁlled the
revised McDonald diagnostic criteria.
15 This study
was approved by the ethics committee of the
Faculty of Medicine, Goethe-University Frankfurt.
Ultrasound examination
Investigations were performed by a trained expert
sonographer (WP), who was blinded to the
MS-patient/healthy control attribution of each
participant. This was achieved by transferring the
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Research paperparticipants to the laboratory by a nurse, comfortably posi-
tioning them on a tilt chair and covering them with a blanket to
cover any hints such as injection marks potentially allowing for
group assignment. Participants were instructed not to talk to
prevent clues by possible dysarthria. The sonographer did not
enter the laboratory until these precautions were taken. A
Philips IU22 (Böblingen, Germany) ultrasound system with an
L9-3 probe was used for assessment of the IJV/VV, and trans-
cranial measurements were performed with an S5-1 probe (both
Philips). Special attention was paid when scanning the IJV not
to exert pressure on the vessel. The investigation was carried out
following the ﬁve criteria suggested by Zamboni et al
5:
1. Reﬂux in the internal jugular veins (IJVs) and/or vertebral
veins (VVs) in the supine and sitting position. Flow
characteristics of both IJVs and VVs were investigated in
08 supine followed by 908 upright sitting positions. Reﬂux in
any vein >0.88 s was considered ‘pathological.’
5 Data were
recorded during a period of 3e5 s of apnoea following normal
exhalation. The probe was located in a longitudinal plane
between vertebrae C6 and C7, which was maintained when
participants changed to upright position.
2. Reﬂux in the deep cerebral veins (DCVs). The Vv. basales
Rosenthal, -cerebri media profunda (VCP) and -Galeni (VG)
were identiﬁed according to standards described elsewhere.
16
In addition, the sinus transversus was assessed. Flow
characteristics in at least one DCV or sinus transversus
were measured. Flow in a reversed direction >0.5 s was
considered ‘pathological.’
5
3. High-resolution B-mode evidence of IJV stenoses. The
narrowest venous cross-sectional area (VCSA) in the acces-
sible parts of the IJV was measured in a transversal plane in
supine position. VCSA #0.3 cm
2 indicated ‘stenosis.’
5
4. Flow not Doppler-detectable in the IJVs and/or VVs. Flow in
both IJVand VV was assessed in supine and upright positions.
Lack of Doppler-detectable ﬂow following deep inspiration
despite a detectable lumen was considered ‘pathological.’
5
5. Reverted postural control of the main cerebral venous outﬂow
route measured in IJV. DVCSAuprightesupine of the IJV was
quantiﬁed. A positive value indicated ‘loss of postural control
of the predominant outﬂow route in the supine position.’
5
The rationale for this modiﬁcation of the respective
“Zamboni-criterion” is explained in table 2 and the Results.
Ofﬂine and statistical analyses
The sonographer performed no data analysis but stored sono-
graphic data as single frames (criteria 3 and 5) or ‘cine’ ﬁles
(criteria 1,2and4).Storeddatawereevaluatedofﬂine byasecond
investigator (‘rater’) who was blinded to all demographics
(including age and gender). Statistical analyses were carried out
on partially unmasked data. The statistician (MWL) was only
aware which subjects belonged to ‘group A’ or ‘group B’ without
knowing which of these groups were patients or controls. Given
all blinding procedures, investigations and analyses were ‘triple-
blind.’ Intergroup comparisons were carried out with the Student
t test after conﬁrmation of normality with QQ plots. Categorial
variables were compared with the Fisher exact test (dichotomous
variables) or the c
2 homogeneity test (more than two categories).
A p value of <0.05 was regarded as statistically signiﬁcant, and all
tests were carried out two-tailed. Data are given as means6SD if
not otherwise indicated. All analyses were carried out with the
SAS 9.1 software package.
RESULTS
Two patients and one healthy control had no transtemporal
ultrasound window. IJVs and VVs were detectable in 95% of
participants in the supine and in 97.5% in the upright position.
Detection rates of at least one DCV reached 92.5% in the supine
and 87.5% in the upright position, thus showing a good match
with the rates reported elsewhere.
16 There was no signiﬁcant
difference in detection rates between MS patients and healthy
controls. Detailed statistics are given in supplementary tables 1, 2.
Reﬂux in the IJVs and/or VVs in supine and sitting position
Flows in IJVs and VVs were strictly orthograde and unidirec-
tional, regardless of position and group. Reﬂux >0.88 s was not
seen in any participant.
Reﬂux in the DCVs
In all 18 MS-patients and 19 controls with detectable DCVs,
ﬂow was strictly orthograde and unidirectional, regardless of
position. Reﬂux >0.5 s was not seen in any participant.
High-resolution B-mode evidence of IJV stenoses
VCSA #0.3 cm
2 was found in the right IJV of 20/40 (50%)
participants, in the left IJV of 27/40 (67.5%) participants and
bilaterally in 18/40 (45%) participants. The combined incidence
was 29/40 (72.5%) participants. The minimum VCSA was
0.3260.15 cm
2 in the right IJV (range 0.05e0.81 cm
2) and
0.2660.17 cm
2 in the left IJV (range 0.03e0.72 cm
2). There was
no signiﬁcant group difference in the incidence of single or
combined ICVeVCSA #0.3 cm
2 (13 MS patients (65%) vs 16
controls (80%), p¼0.48). The minimal right IJV-VCSA was not
different between MS patients and controls (0.3160.13 cm
2 vs
0.3360.19 cm
2,p ¼0.65), while the minimal left IJVeVCSA was
signiﬁcantly larger in MS patients than controls (0.3360.18 cm
2
vs 0.1960.12 cm
2,p ¼0.005).
Table 1 Clinical and demographic data of multiple sclerosis (MS) patients and healthy control subjects
Demographics Relapsing-remitting MS Secondary progressive MS All MS Controls
Subjects, no 17 3 20 20
Mean age, years (SD) 40.3 (13.9) 55.3 (9.3) 42.2 (13.3) 34.3 (11.0)
Sex male/female 5/12 2/1 7/13 10/10
Extended Disability Status Scale range/
median/SD
0e4.5/3/1.3 4e6.5/6/1.3 0e6.5/3/1.7 /
Disease duration, years, range/mean/SD 1e35/11.2/10.2 11e36/23/12.5 1e36/13.1/11.1 /
Patients on medication, no 15/17 3/3 18/20 /
Patients on natalizumab, no/total 10/15 0 10/20 /
Relapses*, no, range/mean/SD 0e4/0.9/1.1 0 0e4/0.9/1.1 /
CSF positivey, no/total 16/17 3/3 19/20 /
MRI positivez, no/total 17/17 3/3 20/20 /
*In the previous 12 months.
yPositive oligoclonal bands.
zCerebral MRI indicative for MS according to Barkhof et al.
14
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Research paperA moderate positive correlation between age and VCSA was
found (right IJV: r¼0.39, p¼0.014; left IJV: r¼0.55, p<0.001).
To exclude potential bias by age interaction in the blinded
analysis, a secondary analysis of a subset of 24 subjects (12 MS
patients, 12 controls) was performed, where MS patients and
controls were randomly drawn matched by age (MS patients:
34.4610.6 years; controls: 34.9611.6 years, p¼0.91). In these
age-matched subpopulations, signiﬁcant group differences in
the minimal VCSA of the right or left IJV were no longer
present.
Flow not Doppler-detectable in the IJVs and/or VVs
In two controls but no MS patients (p¼0.49), venous ﬂow was
absent (13 supine, 13 supine+upright position, left VV) despite
a detectable lumen.
Reverted postural control of the main cerebral venous outﬂow
route measured in IJV
A negative value of DVCSAuprightesupine was found in the IJVs of
all participants. However, this does not indicate ‘loss of postural
control of the predominant outﬂow route in the supine position’
as implicated in the ‘Zamboni protocol’
5 but constitutes the
typical physiological response in healthy subjects.
17e20 There-
fore, a negative value of DVCSAuprightesupine in the IJVs was
considered normal, and the Zamboni criterion was changed to
‘atypical ﬂow,’ indicating a positive value of DVCSAuprightesupine
(see table 2).
Altogether, only one healthy control fulﬁlled $2 criteria for
CCSVI. The results are summarised in table 2.
DISCUSSION
The CCSVI
5 6 hypothesis has attracted signiﬁcant attention in
the media and scientiﬁc community. Endovascular treatment by
percutaneous transluminal angioplasty, as suggested by
Zamboni and coworkers,
7 was, however, complicated by serious
adverse events in two cases.
13 The credibility of the CCSVI
concept has already been questioned by two recent studies
which could not conﬁrm the ﬁndings by Zamboni et al when
using extra- and transcranial colour-coded sonography
21 or
phase-contrast magnetic resonance imaging and contrast-
enhanced magnetic resonance angiography.
22 Here we sought to
replicate the data recently presented by Zamboni et al
5 by using
exactly the same sonography protocol, but for the ﬁrst time in
a triple-blinded controlled study design.
Zamboni and coworkers investigated 65 MS patients and 235
healthy controls in a two-step procedure.
5 First, screening was
performed according to the ‘protocol’ described above. In case of
two or more criteria being fulﬁlled, angiography was applied.
5
Because angiography was conducted unblinded, the validity
of the screening procedure is crucial for the validity of the
whole study.
The ﬁrst criterion of the ‘Zamboni protocol’ claims to assess
extracranial venous ‘reﬂux’ in the IJV and VV by applying
a threshold of 0.88 s to discriminate physiological reversal ﬂow
due to valve closure from longer-lasting reﬂux, assumed to
indicate CCSVI. Thus, deﬁned reﬂux was never seen in our
participants, regardless of group. The validity of this threshold
value is, however, questionable. It stems from a study on IJV
valve insufﬁciency,
23 where retrograde ﬂow jets through insuf-
ﬁcient valves were found to last >1.23 s, while physiological
backward ﬂows during normal valve closure lasted 0.22e0.78 s.
In this context, a threshold of 0.88 s allows for discrimination
between physiological reﬂux during valve closure and retrograde
insufﬁciency ﬂow. This was, however, assessed during
a controlled Valsalva manoeuvre (VM), constituting an entirely
different physiological condition compared with when no VM is
applied, as in the Zamboni study.
5 The rationale for transferring
this threshold, initially established to assess venous valve
insufﬁciency to the unrelated context of CCSVI where it will
serve to assess reﬂux without association to valve insufﬁciency,
remains unclear and is not scientiﬁcally sound; even more so as
conditions of measurement were different by omitting VM.
Furthermore, the ‘Zamboni protocol’ does not require assess-
ment of IJV valves. This is another major shortcoming because
IJV insufﬁciency is directly linked to the function of jugular
valves. Also, the incidence of jugular valve insufﬁciency can be as
high as 29% in the normal population,
23 whereas the incidence
of MS is comparatively very low, approximating 0.03%. There-
fore, reﬂux in the IJV is 1000 times more likely to indicate
insufﬁciency of IJV valves than MS, unless excluded by an
experienced sonographer. While jugular valve insufﬁciency was
shown to be linked to certain neurological disease entities, such
as transient global amnesia and idiopathic intracranial hyper-
tension,
24 25 its direct pathological signiﬁcance has not yet been
established. It may likely be viewed as a non-pathological
phenomenon in a relevant proportion of humans.
Second, Zamboni et al applied a threshold of 0.5 s to
discriminate pathological ‘reﬂux’ in the DCVs, which they found
in 54% of MS patients.
5 In contrast, we did not detect intra-
cranial venous reﬂux in any participant. Transcranial assessment
of ﬂow direction in DCVs is, however, ambitious because mainly
short venous sections with weak duplex signals are detectable.
This may easily lead to misinterpretation of ﬂow direction and
false-positive results. Furthermore, Zamboni et al
5 derived the
Table 2 Fulﬁllment of the ﬁve ‘Zamboni criteria’ in 20 MS patients and 20 healthy controls
Criterion Deﬁnition according to ‘Zamboni protocol’* No of MS patients No of controls p Valuey
1 Reﬂux >0.88 s in the IJVs and/or VVs in sitting or supine position 0 0 /
2 Reﬂux >0.5 s in the deep cerebral veins 0 0 /
3 High resolution B-mode evidence of IJV stenoses deﬁned as VCSA of #0.3 cmyz 13 16 0.48
4 Flow not Doppler-detectable in at least one IJV or VVx in the supine and upright position 0 1x 1.0
5 Atypical main cerebral venous outﬂow measured in IJV deﬁned as DVCSAuprightesupine>0{ 00 /
At least two criteria fulﬁlled 0 1 1.0
*Zamboni et al.
5
yFisher exact test.
zCriterion 3 was not deﬁned consistently by Zamboni et al. We used the deﬁnition in Zamboni et al,
5 where a venous cross-sectional area (VCSA) of #0.3 cm
2 is given as a cut-off value. Doepp
et al
21 obtained different results in assessing criterion 3, but referred to a deviating deﬁnition of ‘stenosis’ given in Zamboni et al,
25a J Neurol Sci 2009;282:21e7, where a local VCSA reduction
of $50% is considered ‘stenotic.’
xCriterion 4 is not speciﬁed clearly by Zamboni et al. Here, we deﬁned criterion 4 as ‘no ﬂow detectable in at least one internal jugular vein (IJV) or vertebral vein (VV) in the supine and the
upright position.’
{This Zamboni criterion was modiﬁed. Given that negative values for DVCSA in the IJV represent not a pathological but a physiological state, this criterion was substituted by ‘atypical ﬂow,’
/, indicates p value could not be calculated. indicating a positive value of DVCSA.
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Research paperthreshold of >0.5 s from phlebological studies in CVI,
26 27 where
it serves to quantify venous valve insufﬁciency following deﬂa-
tion of a tourniquet. The rationale for adopting this value,
validated exclusively for assessment of the posterior tibial vein,
28
to perform a DCV assessment in CCSVI is unclear. Under the
likely assumption of unequal hydrostatic and hydrodynamic
conditions present in the veins of the leg and those of the brain,
failure to validate a threshold criterion for DCV reﬂux consti-
tutes an unjustiﬁed omission that casts doubt on the validity of
any data, based hereupon. Unless a clinical syndrome is veriﬁ-
ably directly linked to chronic venous congestion, we strongly
recommend avoidance of the expression CVI in this context of
cerebral venous drainage.
Third, the ‘Zamboni protocol’ requires assessment of
IJVeVCSA, applying a cut-off value of #0.3 cm
2 that was ‘never
measured in normal subjects’ but reported in 37% of MS
patients.
5 We found an even higher incidence of low IJVeVCSA
(65% in MS patients, 80% in controls). Therefore, IJVeVCSA
#0.3 cm
2 seems unrelated to MS but seems to represent a
common ﬁnding also in healthy adults. Furthermore, the cut-off
applied was taken from a study on a cohort of patients on an
intensive care unit.
29 Those authors found VCSAs #0.4 cm
2 in
23% of 160 IJVs, but because of hypovolaemia, mechanical
ventilation and other confounds, these data are likely unsuitable
to serve as a normative reference for assessment of IJV stenoses.
Another limitation in assessing ‘stenoses’ solely based on
IJVeVCSA is its low speciﬁcity because, owing to thin vessel
walls, even mild pressure exerted by the ultrasound probe
inevitably alters the vein diameter, likely leading to false-positive
results. By measuring venous blood volume ﬂow, which is
independent of these problems, one recent study conducted by
Doepp et al found no difference between MS patients and
healthy controls.
21 These considerations raise serious doubts as
to whether the criterion VCSA of #0.3 cm
2 can be considered
valid with respect to what it aims to measure.
Doepp et al found different results from ours. They did not
detect any venous stenoses in their participants. This incon-
gruence is likely explained by differences in the applied deﬁni-
tions of ‘stenosis’ (see table 2).
Fourth, ‘lack of ﬂow’ in IJVand/or VV despite deep inspiration
was considered to provide indirect evidence for stenosis, and an
incidence of 52% in MS patients but only 3% in the control
group was reported.
5 In contrast, this abnormality was not
observed in any MS patients in the present study. Limitations
arise from an unclear deﬁnition of this criterion (see table 2) but
also from the lack of its validation, which was derived from
a study addressing extrajugular venous drainage pathways.
30
Those authors found evidence for compensational ﬂow increases
in the vertebral plexus, while in 3/50 subjects, a jugular ﬂow of
<30% of global arterial blood ﬂow was seen despite a detectable
lumen; this ﬁnding, however, was never discussed in the context
of ‘stenosis.’ Moreover, ﬂow assessments were performed at rest
rather than during deep inspiration, which constitutes a
different physiological state.
20
The ﬁfth screening parameter, a negative value of IJVe
VCSAuprightesupine, was claimed to reﬂect ‘loss of postural
control of the predominant outﬂow route in the supine position’
and reported in 55% of the MS patients.
5 All of the participants
of our study showed negative VCSA values. Negative ΔVCSA,
however, reﬂects normal conditions in healthy subjects, as
predominant outﬂow via IJV in the supine but via VVand deep
cerebral veins in the upright position is typically found.
31
Moreover, careful revisitation of the studies cited by Zamboni
et al
5 reveals that a negative ΔVCSA reﬂects indeed the physi-
ological cerebral venous drainage in healthy subjects.
17e20
Zamboni et al
5 can be interpreted only by assuming that they
accidentally confused ΔVCSA>0 (pathological) with ΔVCSA<0
(physiological).
Ultrasound-based investigation of vessels is known to be
susceptible to rater-bias, which becomes an increasingly important
issue, when venous signals with an unfavourable signal-to-noise
ratio are assessed. Therefore, blinding of sonographer and rater as
to the attribution of participants to the patient versus control
group within a study setting is crucial. The precautions applied by
Zamboni and coworkers, however, remained undeﬁned, and hence
the question arises, as to how reliably blinding was accomplished.
In our study, sophisticated blinding procedures were applied to
ensure the highest possible standards. In doing so, we found no
evidence for ‘venous congestion’ in MS, despite an adoption of the
‘Zamboni protocol’ that was otherwise as accurate as possible.
5
After the ultrasound assessment was found to be positive in
all 65 MS patients enrolled in their study, Zamboni and
coworkers performed and rated venography in an unblinded
manner, revealing ‘stenoses’ of the major venous conductors in
variable locations in each patient but none of the 48 controls.
5
This perfect association of 100% constitutes a very uncommon
ﬁnding in biological systems, and therefore careful interpretation
of those data is warranted.
The hypothesis of CCSVI raises further questions concerning
conceptual plausibility. In correlating four distinct topographical
patterns of ‘venous obstruction’ detected in MS-patients with
clinical course, Zamboni et al stated a signiﬁcant correlation
(p<0.0001) between the pattern of bilateral IJV stenosis with
both RRMS (44%) and SPMS (56%)
5 which suggested that
bilateral IJV stenoses predispose for the development of MS.
Evidence for higher incidences of MS in patients after bilateral
neck dissection, which would match complete bilateral IJV
occlusion, is, however, lacking. In contrast, venous ﬂow assess-
ments suggested the coexistence of efﬁcient extrajugular drainage
pathways instead of showing signs of congestion.
32 Convincing
evidence exists for the paramount relevance of dynamic extra-
jugular pathways, sufﬁciently taking over drainage in case of
jugular ﬂow reduction.
20 The capability of the intraspinal and
extraspinal vertebral venous system, buffering up to 1000 ml,
33 is
attributed to the valveless and freely communicating architecture
of vertebral venous networks as well as the presumably huge
cumulative VCSA, most likely surpassing and easily substituting
that of both IJV.
34 35 Accordingly, a signiﬁcant threefold increase
in volume ﬂow of those veins was demonstrated following
bilateral IJV obstruction.
20 These data also indicate that venous
cerebral drainage cannot be accurately assessed by measurements
limited to the IJVs and VVs, but will require additional assess-
ment of the capacity of substitute drainage pathways such as
deep cervical veins, epidural and paravertebral plexus.
Within the pathophysiological concept of CCSVI,
6 signiﬁ-
cantly elevated transmural pressure constitutes a mandatory
requirement. Elevated CSF pressure, analogous to the concept of
venous congestion in idiopathic intracranial hypertension,
should therefore be a regular consequence of obstructed cerebral
venous drainage in CCSVI.
36 Zamboni et al did not obtain such
data from their patients. However, other studies showed normal
CSF pressure after bilateral neck dissection unless further
obstructing deep cervical drainage pathways by manual pres-
sure.
37 These ﬁndings stress the functional relevance of deep
cervical components for cerebral venous drainage in case of
complete bilateral IJV obliteration and are clearly non-conﬁr-
mative for the proposed pathophysiology of CCSVI. In turn,
raised intracranial pressure in MS patients is only rarely
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caused by extensive space-occupying inﬂammatory lesions.
38
Notwithstanding the clear differences from the well-known
pathophysiology of CVI of the lower limbs, Zamboni suggested
local extravasation of erythrocytes, driven by elevated trans-
mural venous pressure, followed by degradation and consecutive
forming of perivenous iron deposits as the core pathophysio-
logical mechanisms of CCSVI.
6 Perivascular iron is claimed to be
a potent chemoattractant, so that local formation of MS lesions
is interpreted as a side effect of iron phagocytosis. While
leucocytes can be targeted through vascular walls upon induc-
tion of a well-characterised apparatus involving adhesion mole-
cules and ectoenzymes, erythrocytes lack all of the respective
proteins. The concept of pressure-induced extravasation of
erythrocytes through veins ignores basic features of the archi-
tecture of brain vessels and the braineblood barrier. Most
importantly, veins and venules, by deﬁnition, possess a vascular
wall and a tight endothelium, which certainly is non-permissive
for cells.
39 Furthermore, one recent investigation showed normal
CSF ferritin levels in MS patients which serves as another piece
of evidence against an aetiological role for CCSVI-related
parenchymal iron deposition in MS.
40
The current understanding of MS opens a view far beyond the
single lesion. The hypothesis of CCSVI therefore ultimately fails
in attempting to explain MS solely on the basis of perivenous
MS lesions. This hypothesis cannot account for the sea of
neurodegeneration surrounding the lesion; nor can it explain the
vast heterogeneity of MS.
Limitations
One limitation of this study is a relatively small sample size.
Small effects may be missed unless larger studies are performed.
However, an effect of the magnitude claimed by Zamboni et al
5
can be ruled out with sufﬁcient certainty by the present ﬁnd-
ings. Second, the question as to whether or not abnormalities of
the major venous conductors may be over-represented in MS
patients was beyond the aim and scope of this study. Evidence
pertinent to this issue will only become available from further
independent venographic or contrast-enhanced sonographic
investigations.
Conclusion
This triple-blinded controlled study does not support insufﬁcient
extra- and intracranial venous ﬂow in MS. Together with two
other recent studies,
21 22 this constitutes compelling evidence
against a signiﬁcant contribution of CCSVI to the pathogenesis of
MS. As interventional procedures such as transluminal angio-
plasty are derived from the non-conﬁrmed CCSVI concept
7 and
can result in serious adverse events,
13 we strongly discourage the
use of these procedures on the grounds of the present evidence.
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